The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Molecular genetics of prostate cancer
Open accessAbstract
Prostate cancer afflicts one man in nine over the age of 65 and represents the most frequently diagnosed cancer in American men (Coffey 1993).Early detection through serum testing for prostate specific antigen (PSA) and improved procedures for surgical intervention and radiation therapy have significantly reduced the number of fatalities; however, there is still no effective cure for men with advanced disease.Therefore, much research has been dedicated to identifying prognostic markers that distinguish indolent versus aggressive forms of prostate cancer.In contrast, significantly less research has been devoted to understanding the molecular mechanisms that underlie normal prostate growth and development or cancer initiation and progression.In this review, we address recent progress toward the central objectives of understanding parameters of normal versus abnormal prostatic development and of elucidating a molecular pathway for prostate cancer progression.We focus on key regulatory molecules that have been implicated by analysis of patterns of allelic loss in human prostate cancers and/or by reverse genetic approaches in the mouse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,855
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Emmert-Buck, M. R., Bonner, R. F., Smith, P. D., Chuaqui, R. F., Zhuang, Z., Goldstein, S. R., Weiss, R. A., & Liotta, L. A. (1996) · Science · doi:10.1126/science.274.5289.998 · Cited by 2,534
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484 · cited 2×
“1996), and amplification of the entire AR gene, which may be prevalent in recurrent disease (Visakorpi et al. 1995a; Koivisto et al. 1998).”
Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium
Olumi, A., Grossfeld, G., Hayward, S., Carroll, P., Cunha, G., Hein, P., & Tlsty, T. (2000) · Breast Cancer Research · doi:10.1186/bcr138 · Cited by 1,463
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
Prostate cancer in a transgenic mouse.
Greenberg, N. M., DeMayo, F., Finegold, M. J., Medina, D., Tilley, W. D., Aspinall, J. O., Cunha, G. R., Donjacour, A. A., Matusik, R. J., & Rosen, J. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.8.3439 · Cited by 1,294
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · cited 1×
“The recent development of mouse models with telomerase dysfunction should facilitate such functional studies of telomerase activity in prostate carcinogenesis (Lee et al. 1998).”
Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer
Taplin, M.-E., Bubley, G. J., Shuster, T. D., Frantz, M. E., Spooner, A. E., Ogata, G. K., Keer, H. N., & Balk, S. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505253322101 · Cited by 1,253
BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.6961 · Cited by 1,252 · cited 1×
“Although Bcl2 expression is restricted to basal cells in the normal prostate (Hockenbery et al. 1991), forced expression of Bcl2 in LnCAP prostate carcinoma cells protects against apoptosis induced by androgen depletion (Raffo et al.”
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The Endocrinology and Developmental Biology of the Prostate*
CUNHA, G. R., DONJACOUR, A. A., COOKE, P. S., MEE, H., BIGSBY, R. M., HIGGINS, S. J., & SUGIMURA, Y. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-3-338 · Cited by 1,036
Histologic grading of prostate cancer: A perspective
Gleason, D. F. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90108-f · Cited by 1,034
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., & Parsons, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.4.1563 · Cited by 946
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899
Proliferative Inflammatory Atrophy of the Prostate
De Marzo, A. M., Marchi, V. L., Epstein, J. I., & Nelson, W. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65517-4 · Cited by 872
Suzuki, A., de la Pompa, J. L., Stambolic, V., Elia, A. J., Sasaki, T., Barrantes, I. D. B., Ho, A., Wakeham, A., ltie, A., Khoo, W., et al. (1998) · Current Biology · doi:10.1016/s0960-9822(07)00488-5 · Cited by 818
Sun, H., Lesche, R., Li, D.-M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X., & Wu, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6199 · Cited by 796
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Mendelian inheritance of familial prostate cancer.
Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., & Walsh, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3367 · Cited by 781
KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2
Dong, J.-T., Lamb, P. W., Rinker-Schaeffer, C. W., Vukanovic, J., Ichikawa, T., Isaacs, J. T., & Barrett, J. C. (1995) · Science · doi:10.1126/science.7754374 · Cited by 757
The Frequency of Carcinoma and Intraepithelial Neoplasia of the Prostate in Young Male Patients
Sakr, W. A., Haas, G. P., Cassin, B. F., Pontes, J. E., & Crissman, J. D. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35487-3 · Cited by 745
Thalmann, G. N., Anezinis, P., Chang, S., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., & Chung, L. W. K. (1994) · PubMed · Cited by 727
Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*
KYPRIANOU, N., & ISAACS, J. T. (1988) · Endocrinology · doi:10.1210/endo-122-2-552 · Cited by 720
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujnovszky, P., Bova, G. S., et al. (1998) · Nature Genetics · doi:10.1038/2477 · Cited by 690
Normal Histology of the Prostate
McNeal, J. E. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198808000-00003 · Cited by 674
Wu, X., Senechal, K., Neshat, M. S., Whang, Y. E., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15587 · Cited by 674
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
Reiter, R. E., Gu, Z., Watabe, T., Thomas, G., Szigeti, K., Davis, E., Wahl, M., Nisitani, S., Yamashiro, J., Le Beau, M. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1735 · Cited by 673
Roles for Nkx3.1 in prostate development and cancer
Bhatia-Gaur, R., Donjacour, A. A., Sciavolino, P. J., Kim, M., Desai, N., Young, P., Norton, C. R., Gridley, T., Cardiff, R. D., Cunha, G. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.966 · Cited by 665
Self-citationMcMenamin, M. E., Soung, P., Perera, S., Kaplan, I. D., Loda, M. F., & Sellers, W. R. (1999) · PubMed · Cited by 640
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F. M., Schaafsma, H. E., Debruyne, F. M. J., & Isaacs, W. B. (1992) · PubMed · Cited by 611
Metastatic prostate cancer in a transgenic mouse.
Gingrich, J. R., Barrios, R. J., Morton, R. A., Boyce, B. F., DeMayo, F. J., Finegold, M. J., Angelopoulou, R., Rosen, J. M., & Greenberg, N. M. (1996) · PubMed · Cited by 599
Bubendorf, L., Kononen, J., Koivisto, P. A., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G., & Kallioniemi, O. (1999) · PubMed · Cited by 594
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska, M., Krajewski, S., Epstein, J. I., Shabaik, A. S., Sauvageot, J., Song, K. B., Kitada, S., & Reed, J. C. (1996) · Europe PMC (PubMed Central) · Cited by 593
Colombel, M. C., Symmans, W. F., de Medina, S. G. D., O’Toole, K., Chopin, D. K., Benson, M. C., Olsson, C. A., Korsmeyer, S. J., & Buttyan, R. (1993) · PubMed · Cited by 591
Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene
Bookstein, R., Shew, J.-Y., Chen, P.-L., Scully, P., & Lee, W.-H. (1990) · Science · doi:10.1126/science.2300823 · Cited by 591
Intraductal dysplasia: A premalignant lesion of the prostate
McNeal, J. E., & Bostwick, D. G. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80156-3 · Cited by 573
Etiology and disease process of benign prostatic hyperplasia
Isaacs, J. T., & Coffey, D. S. (1989) · The Prostate · doi:10.1002/pros.2990150506 · Cited by 558
Raffo, A. J., Perlman, H., Chen, M., Day, M. L., Streitman, J., & Buttyan, R. (1995) · PubMed · Cited by 542
Origin and evolution of benign prostatic enlargement.
McNeal, J. E. (1978) · PubMed · Cited by 539
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Umbas, R., Isaacs, W. B., Bringuier, P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J., & Schalken, J. A. (1994) · PubMed · Cited by 529
Wu, H., Hsieh, J., Gleave, M. E., Brown, N. M., Pathak, S., & Chung, L. W. K. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570319 · Cited by 499
Cardiff, R. D., Anver, M. R., Gusterson, B. A., Hennighausen, L., Jensen, R. A., Merino, M. J., Rehm, S., Russo, J., Tavassoli, F. A., Wakefield, L. M., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203277 · Cited by 489
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
Visakorpi, T., Kallioniemi, A. H., Syvänen, A. C., HYYTINEN, E.-R., Karhu, R., Tammela, T. L. J., Isola, J. J., & Kallioniemi, O. (1995) · PubMed · Cited by 480
p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma
Navone, N. M., Troncoso, P., Pisters, L. L., Goodrow, T. L., Palmer, J. L., Nichols, W. W., Eschenbach, A. C. V., & Conti, C. J. (1993) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/85.20.1657 · Cited by 478
Allelic loss of chromosomes 16q and 10q in human prostate cancer.
Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., & Isaacs, W. B. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8751 · Cited by 457
Suzuki, H., Freije, D., Nusskern, D. R., Okami, K., Cairns, P., Sidransky, D., Isaacs, W. B., & Bova, G. S. (1998) · PubMed · Cited by 452
Veldscholte, J., Berrevoets, C. A., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Trapman, J., Brinkmann, A. O., & Mulder, E. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90401-4 · Cited by 446
Gu, Z., Thomas, G., Yamashiro, J., Shintaku, I. P., Dorey, F., Raitano, A., Witte, O., Said, J., Loda, M., & Reiter, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203426 · Cited by 436
Androgen receptor gene mutations in human prostate cancer.
Newmark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., & Barrack, E. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6319 · Cited by 419
Bonkhoff, H., & Remberger, K. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(199602)28:2<98::aid-pros4>3.0.co;2-j · Cited by 416
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer.
Esposito, V., Baldi, A., Luca, A. D., Gröger, A. M., Loda, M. F., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., & Giordano, A. (1997) · PubMed · Cited by 415
Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues, P., Schäuble, B., Hausen, A. Z., Estève, J., & Ohgaki, H. (1997) · Europe PMC (PubMed Central) · Cited by 411
Isaacs, J. T., Isaacs, W. B., Feitz, W. F. J., & Scheres, J. (1986) · The Prostate · doi:10.1002/pros.2990090306 · Cited by 407
Morphogenesis of Ductal Networks in the Mouse Prostate1
Sugimura, Y., Cunha, G. R., & Donjacour, A. A. (1986) · Biology of Reproduction · doi:10.1095/biolreprod34.5.961 · Cited by 407
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Klein, K. A., Reiter, R. E., Redula, J., Moradi, H., Zhu, X. L., Brothman, A. R., Lamb, D. J., Marcelli, M., Belldegrun, A., Witte, O. N., et al. (1997) · Nature Medicine · doi:10.1038/nm0497-402 · Cited by 399
Tilley, W. D., Buchanan, G., Hickey, T. E., & Bentel, J. M. (1996) · PubMed · Cited by 396
Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld, H. J., Meeker, A. K., Piatyszek, M. A., Bova, G. S., Shay, J. W., & Coffey, D. S. (1996) · PubMed · Cited by 391
Cher, M. L., Bova, G. S., Moore, D. H., Small, E. J., Carroll, P. R., Pin, S. S., Epstein, J. I., Isaacs, W. B., & Jensen, R. H. (1996) · PubMed · Cited by 391
Di Sant'Agnese, P. A. (1992) · Cancer · doi:10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-e · Cited by 387
Androgen receptors in endocrine‐therapy‐resistant human prostate cancer
van der Kwast, T. H., Schalken, J., de Winter, J. A. R., van Vroonhoven, J. C. C., Mulder, E., Boersma, W., & Trapman, J. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480206 · Cited by 386
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
Vlietstra, R. J., van Alewijk, D. C., Hermans, K., van Steenbrugge, G. J., & Trapman, J. (1998) · PubMed · Cited by 381
Isaacs, J. T., & Coffey, D. S. (1981) · PubMed · Cited by 371
Neuroendocrine differentiation in prostatic carcinoma
Abrahamsson, P.-A. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · Cited by 370
Maroulakou, I. G., Anver, M., Garrett, L., & Green, J. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11236 · Cited by 363
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
Gaddipati, J. P., McLeod, D. G. R., Heidenberg, H. B., Sesterhenn, I. A., Finger, M. J., Moul, J. W., & Srivastava, S. (1994) · PubMed · Cited by 363
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
Bova, G. S., Carter, B. S., Bussemakers, M. J. G., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., & Walsh, P. C. (1993) · PubMed · Cited by 363
Androgen-independent prostate cancer progression in the TRAMP model.
Gingrich, J. R., Barrios, R. J., Kattan, M. W., Nahm, H. S., Finegold, M. J., & Greenberg, N. M. (1997) · PubMed · Cited by 362
p53 is mutated in a subset of advanced-stage prostate cancers.
Bookstein, R., MacGrogan, D., Hilsenbeck, S. G., Sharkey, F. E., & Allred, D. C. (1993) · PubMed · Cited by 362
He, W. W., Sciavolino, P. J., Wing, J., Augustus, M., Hudson, P., Meissner, P. S., Curtis, R. T., Shell, B. K., Bostwick, D. G., Tindall, D. J., et al. (1997) · Genomics · doi:10.1006/geno.1997.4715 · Cited by 361
Self-citationp27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
Ponce-Castañeda, M. V., Lee, M.-H., Latres, E., Polyák, K., Lacombe, L., Montgomery, K., Mathew, S., Krauter, K., Sheinfeld, J., & Massagué, J. (1995) · PubMed · Cited by 354
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Implication of cell kinetic changes during the progression of human prostatic cancer.
Berges, R. R., Vukanovic, J., Epstein, J. I., CarMichel, M., Cisek, L. J., Johnson, D. E., Veltri, R. W., Walsh, P. C., & Isaacs, J. T. (1995) · PubMed · Cited by 349
Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma.
Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., & Lee, W. H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7762 · Cited by 334
(1994) · PubMed Central · Cited by 328
Tsihlias, J., Kapusta, L. R., Deboer, G., Morava-Protzner, I., Zbieranowski, I., Bhattacharya, N., Catzavelos, G. C., Lh, K., & Slingerland, J. (1998) · PubMed · Cited by 325
The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human Cancer
Tsihlias, M., Kapusta, M., & Slingerland, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.401 · Cited by 319
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)98734-r · Cited by 312
Dong, J., Suzuki, H., Pin, S. S., Bova, G. S., Schalken, J. A., Isaacs, W. B., Barrett, J. C., & Isaacs, J. T. (1996) · PubMed · Cited by 307
Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation
Visakorpi, T., Kallioniemi, O.-P., Heikkinen, A., Koivula, T., & Isola, J. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.11.883 · Cited by 304
Cordon-Cardo, C., Koff, A., Drobnjak, M., Capodieci, P., Osman, I., Millard, S. S., Gaudin, P. B., Fazzari, M., Zhang, Z.-F., Massague, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1284 · Cited by 300
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.
Emmert‐Buck, M. R., Vocke, C. D., Pozzatti, R., Duray, P. H., Jennings, S. B., Florence, C., Zhuang, Z., Bostwick, D. G., Liotta, L. A., & Linehan, W. M. (1995) · PubMed · Cited by 293
Craft, N. A., Chhor, C. M., Tran, C., Belldegrun, A. S., deKernion, J. B., Witte, O. N., SAID, J. W., Reiter, R. E., & Sawyers, C. L. (1999) · PubMed · Cited by 292
Morton, R. A., Ewing, C. M., Nagafuchi, A., Tsukita, S., & Isaacs, W. B. (1993) · PubMed · Cited by 292
Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma
Bergerheim, U. S. R., Kunimi, K., Collins, V. P., & Ekman, P. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030308 · Cited by 290
Dunn, N. R., Winnier, G. E., Hargett, L. K., Schrick, J. J., Fogo, A. B., & Hogan, B. L. M. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8664 · Cited by 286
Distant metastases from prostatic carcinoma express androgen receptor protein.
Hobisch, A., CULIG, Z., Radmayr, C., Bartsch, G., Klocker, H., & Hittmair, A. (1995) · PubMed · Cited by 283
Davies, M. A., Koul, D., Dhesi, H., Berman, R. S., McDonnell, T. J., McConkey, D. J., Yung, W. K. A., & Steck, P. A. (1999) · PubMed · Cited by 280
LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)63776-5 · Cited by 278
C-met Proto-Oncogene Expression in Benign and Malignant Human Prostate Tissues
Pisters, L. L., Troncoso, P., Zhau, H. E., Li, W., von Eschenbach, A. C., & Chung, L. W. K. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67297-5 · Cited by 269
Greenberg, N. M. (1994) · Molecular Endocrinology · doi:10.1210/me.8.2.230 · Cited by 267
Borgström, P., Bourdon, M. A., Hillan, K. J., Sriramarao, P., & Ferrara, N. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980401)35:1<63::aid-pros9>3.0.co;2-i · Cited by 247
STEM CELL FEATURES OF BENIGN AND MALIGNANT PROSTATE EPITHELIAL CELLS
DE MARZO, A. M., NELSON, W. G., MEEKER, A. K., & COFFEY, D. S. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62196-7 · Cited by 239
Kasper, S. F., Sheppard, P. C., Yan, Y., Pettigrew, N. M., Borowsky, A. D., Prins, G. S., Dodd, J. G., Duckworth, M. L., & Matusik, R. J. (1998) · PubMed · Cited by 235
Loss of the chromosomal region 10q23-25 in prostate cancer.
Gray, I. C., Phillips, S. M. A., Lee, S. J., Neoptolemos, J. P., Weissenbach, J., & Spurr, N. K. (1995) · PubMed · Cited by 232
Bonkhoff, H., Stein, U., & REMBERGER, K. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90169-4 · Cited by 232
Morphological and Functional Heterogeneity in the Rat Prostatic Gland1
Hayashi, N., Sugimura, Y., Kawamura, J., Donjacour, A. A., & Cunha, G. R. (1991) · Biology of Reproduction · doi:10.1095/biolreprod45.2.308 · Cited by 231
Prostate Stem Cell Compartments
De Marzo, A. M., Meeker, A. K., Epstein, J. I., & Coffey, D. S. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65632-5 · Cited by 230
Analysis of PTEN and the 10q23 region in primary prostate carcinomas
Feilotter, H. E., Nagai, M. A., Boag, A. H., Eng, C., & Mulligan, L. M. (1998) · Oncogene · doi:10.1038/sj.onc.1200205 · Cited by 230
Kaplan, P. J., Mohan, S., Cohen, P., Foster, B. A., & Greenberg, N. M. (1999) · PubMed · Cited by 228
Bauer, J. J., Sesterhenn, I. A., Mostofi, F. K., McLeod, D. G., Srivastava, S., & Moul, J. W. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65641-6 · Cited by 225
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone.
Drobnjak, M., Osman, I., Scher, H. I., Fazzari, M. J., & Cordon‐Cardo, C. (2000) · PubMed · Cited by 221
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Wang, S. I., Parsons, R. E., & Ittmann, M. (1998) · PubMed · Cited by 218
Prostate Development Requires Sonic Hedgehog Expressed by the Urogenital Sinus Epithelium
Podlasek, C. A., Barnett, D. H., Clemens, J. Q., Bak, P. M., & Bushman, W. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9229 · Cited by 218
Androgen receptor gene expression in human prostate carcinoma cell lines.
Tilley, W. D., Wilson, C. M., Marcelli, M., et al. (1990) · PubMed · Cited by 218
Cell–cell interaction in prostate gene regulation and cytodifferentiation
Liu, A. Y., True, L. D., LaTray, L., Nelson, P. S., Ellis, W. J., Vessella, R. L., Lange, P. H., Hood, L., & van den Engh, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10705 · Cited by 202
Mutation of the MXI1 gene in prostate cancer
Eagle, L. R., Yin, X., Brothman, A. R., Williams, B. J., Atkin, N. B., & Prochownik, E. V. (1995) · Nature Genetics · doi:10.1038/ng0395-249 · Cited by 201
Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias.
Pietenpol, J. A., Bohlander, S. K., Sato, Y., Papadopoulos, N., Liu, B., Friedman, C., Trask, B. J., Roberts, J. M., Kinzler, K. W., & Rowley, J. D. (1995) · PubMed · Cited by 200
Guo, Y., Sklar, G. N., Borkowski, A., & Kyprianou, N. (1997) · PubMed · Cited by 200
Bostwick, D. G., Shan, A., Qian, J., Darson, M. F., Maihle, N. J., Jenkins, R. B., & Liang Cheng, C. (1998) · Cancer · Cited by 199
Androgen receptor gene and hormonal therapy failure of prostate cancer.
Koivisto, P. A., Kolmer, M., Visakorpi, T., & Kallioniemi, O. (1998) · Europe PMC (PubMed Central) · Cited by 196
Cher, M. L., Macgrogan, D., Bookstein, R., Brown, J. A., Jenkins, R. B., & Jensen, R. H. (1994) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870110304 · Cited by 193
Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H.-W., & DePinho, R. A. (1998) · Nature · doi:10.1038/31008 · Cited by 192
Cote, R. J., Shi, Y., Groshen, S. G., Feng, A., Skinner, D. G., Lieskovosky, G., & Cordon‐Cardo, C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.916 · Cited by 191
Mackey, T. J., Borkowski, A., Amin, P., Jacobs, S. C., & Kyprianou, N. (1998) · Urology · doi:10.1016/s0090-4295(98)00360-4 · Cited by 190
Murphy, G. P., Tjoa, B. A., Simmons, S. J., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Troychak, M. J., Salgaller, M. L., & Boynton, A. L. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990401)39:1<8::aid-pros2>3.0.co;2-n · Cited by 185
The ?6?1 and ?6?4 integrins in human prostate cancer progression
Cress, A. E., Rabinovitz, I., Zhu, W., & Nagle, R. B. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690293 · Cited by 185
Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.
Tulinius, H., Egilsson, V., Olafsdóttir, G. H., & Sigvaldason, H. (1992) · BMJ · doi:10.1136/bmj.305.6858.855 · Cited by 184
Precise microdissection of human prostate cancers reveals genotypic heterogeneity.
Macintosh, C. A., Stower, M. J., Reid, N., & Maitland, N. J. (1998) · PubMed · Cited by 181
p53 in Prostate Cancer: Frequent Expressed Transition Mutations
Chi, S.-G., deVere White, R. W., Meyers, F. J., Siders, D. B., Lee, F., & Gumerlock, P. H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.12.926 · Cited by 179
Ductal Budding and Branching Patterns in the Developing Prostate
Timms, B. G., Mohs, T. J., & Didio, L. J. A. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35273-4 · Cited by 179
Tissue-specific expression of murineNkx3.1 in the male urogenital system
Sciavolino, P. J., Abrams, E. W., Yang, L., Austenberg, L. P., Shen, M. M., & Abate-Shen, C. T. (1997) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199705)209:1<127::aid-aja12>3.0.co;2-z · Cited by 178
Self-citationA transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells
Garabedian, E. M., Humphrey, P. A., & Gordon, J. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15382 · Cited by 177
Verhagen, A. P. M., Aalders, T. W., Ramaekers, F. C. S., Debruyne, F. M. J., & Schalken, J. A. (1988) · The Prostate · doi:10.1002/pros.2990130104 · Cited by 175
Jarrard, D. F., Bova, G. S., Ewing, C. M., Pin, S. S., Nguyen, S. H., Baylin, S. B., Cairns, P., Sidransky, D., Herman, J. G., & Isaacs, W. B. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199706)19:2<90::aid-gcc4>3.0.co;2-v · Cited by 175
Gleave, M. E., Tolcher, A. W., Miyake, H., Nelson, C. C., Brown, R. E., Beraldi, E., & Goldie, J. H. (1999) · PubMed · Cited by 175
Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cunningham, J. M., Shan, A., Wick, M. J., McDonnell, S. K., Schaid, D. J., Tester, D. J., Qian, J., Takahashi, S., Jenkins, R. B., Bostwick, D. G., et al. (1996) · PubMed · Cited by 174
Alteration of the Tumor Suppressor Gene p53 in a High Fraction of Hormone Refractory Prostate Cancer
Heidenberg, H. B., Sesterhenn, I. A., Gaddipati, J. P., Weghorst, C. M., Buzard, G. S., Moul, J. W., & Srivastava, S. K. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67065-4 · Cited by 172
The Relationship Between Prostatic Intraepithelial Neoplasia and Prostate Cancer: Critical Issues
Haggman, M. J., Macoska, J. A., Wojno, K. J., & Oesterling, J. E. (1997) · Journal of Urology · doi:10.1097/00005392-199707000-00004 · Cited by 168
Dysregulated expression of growth factors and their receptors in the development of prostate cancer
Djakiew, D. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000201)42:2<150::aid-pros10>3.0.co;2-h · Cited by 165
Prognostic significance of Bcl-2 in clinically localized prostate cancer.
Bubendorf, L., Sauter, G., Moch, H., Jordan, P., Blöchlinger, A., Gasser, T. C., & Mihatsch, M. J. (1996) · Europe PMC (PubMed Central) · Cited by 160
Jarrard, D. F., Sarkar, S., Shi, Y., Yeager, T. R., Magrane, G., Kinoshita, H., Nassif, N., Meisner, L. F., Newton, M. A., Waldman, F. M., et al. (1999) · PubMed · Cited by 157
Ellis, W. J., Vessella, R. L., Buhler, K. R., Bladou, F., True, L. D., Bigler, S. A., Curtis, D., & Lange, P. H. (1996) · PubMed · Cited by 153
Phillips, S. M. A., Barton, C., Lee, S. J., Morton, D. G., Wallace, D., Lemoine, N. R., & Neoptolemos, J. P. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.482 · Cited by 152
Cytokeratin characterization of human prostatic carcinoma and its derived cell lines.
Nagle, R. B., Ahmann, F. R., Mcdaniel, K. M., Paquin, M. L., Clark, V. A., & Celniker, A. C. (1987) · PubMed · Cited by 152
p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice
Park, M. S., Rosaí, J., Nguyen, H. T., Capodieci, P., Cordon‐Cardo, C., & Koff, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6382 · Cited by 147
Zhang, W., Kapusta, L. R., Slingerland, J. M., & Klotz, L. H. (1998) · PubMed · Cited by 147
THE EPIDEMIOLOGY OF PLASMA TESTOSTERONE LEVELS IN MIDDLE-AGED MEN
Dai, W. S., Kuller, L. H., LaPorte, R. E., Gutai, J. P., Falvo-Gerard, L., & Caggiula, A. W. (1981) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113251 · Cited by 146
Epidemiologic evidence regarding predisposing factors to prostate cancer
Carter, B. S., Carter, H. B., & Isaacs, J. T. (1990) · The Prostate · doi:10.1002/pros.2990160302 · Cited by 145
Elo, J. P., Kvist, L. J., Leinonen, K. A., ISOMAA, V. V., Henttu, P. M. A., Lukkarinen, O. A., & Vihko, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530589 · Cited by 143
Expression of bcl-2 and the progression of human and rodent prostatic cancers.
Furuya, Y., Krajewski, S., Epstein, J. I., Reed, J. C., & Isaacs, J. T. (1996) · PubMed · Cited by 143
Theodorescu, D., Broder, S. R., Boyd, J. C., Mills, S. E., & Frierson, H. F. (1997) · The Journal of Urology · doi:10.1097/00005392-199707000-00040 · Cited by 139
McDonnel, T. J., Navone, N. M., Troncoso, P., Pisters, L. L., Conti, C. J., von Eschenbach, A. C., Brisbay, S. M., & Logothetis, C. J. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)65204-2 · Cited by 137
Apakama, I., Robinson, M., Walter, N., Charlton, R., Royds, J., Fuller, C., Neal, D. E., & Hamdy, F. C. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.526 · Cited by 137
Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J. W., Hsiao, P., Wang, C., Su, C.-Y., & Chang, C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8974 · Cited by 135
Prostate cancer. An overview of an increasing dilemma
Coffey, D. S. (1993) · Cancer · Cited by 133
Lü, X., Park, S. H., Thompson, T. C., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90541-j · Cited by 132
Miyake, H., Tolcher, A. W., & Gleave, M. E. (1999) · PubMed · Cited by 132
Inactivation of the p53 pathway in prostate cancer: impact on tumor progression.
Osman, I., Drobnjak, M., Fazzari, M. J., Ferrara, J., Scher, H. I., & Cordon‐Cardo, C. (1999) · PubMed · Cited by 131
PTEN/MMAC1/TEP1 involvement in primary prostate cancers
Pesche, S., Latil, A., Muzeau, F., Cussenot, O., Fournier, G., Longy, M., Eng, C., & Lidereau, R. (1998) · Oncogene · doi:10.1038/sj.onc.1202081 · Cited by 131
An uncertain role for p53 gene alterations in human prostate cancers.
Brooks, J. D., Bova, G. S., Ewing, C. M., Piantadosi, S., Carter, B. S., Robinson, J. C., Epstein, J. I., & Isaacs, W. B. (1996) · PubMed · Cited by 130
On the prevention and therapy of prostate cancer by androgen administration.
Prehn, R. T. (1999) · PubMed · Cited by 130
Sherwood, E. R., Berg, L. A., Mitchell, N. J., McNeal, J. E., Kozlowski, J. M., & Lee, C. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39903-2 · Cited by 128
Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization
Joos, S., Bergerheim, U. S. R., Pan, Y., Matsuyama, H., Bentz, M., du Manoir, S., & Lichter, P. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140405 · Cited by 127
DEVELOPMENTAL PATTERNS OF PLASMA AND TESTICULAR TESTOSTERONE IN MICE FROM BIRTH TO ADULTHOOD
Jean‐Faucher, C., Berger, M., de Turckheím, M., VEYSSIERE, G., & Jean, C. (1978) · European Journal of Endocrinology · doi:10.1530/acta.0.0890780 · Cited by 126
Wang, Y. Z., & Wong, Y. C. (1998) · The Prostate · Cited by 123
Male accessory sex organ morphogenesis is altered by loss of function of Hoxd-13
Podlasek, C. A., Duboule, D., & BUSHMAN, W. A. (1997) · Developmental Dynamics · Cited by 120
Mechanisms, Hypotheses and Questions Regarding Prostate Cancer Micrometastases to Bone
Lange, P. H., & Vessella, R. L. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006106209527 · Cited by 118
Takahashi, S., Shan, A., Ritland, S., Delacey, K., Bostwick, D. G., Lieber, M. M., Thibodeau, S. N., & Jenkins, R. B. (1995) · PubMed · Cited by 117
Xu, L., Srikantan, V., Sesterhenn, I. A., Augustus, M., Dean, R. C., Moul, J. W., Carter, K. C., & Srivastava, S. K. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67867-6 · Cited by 111
Ct, L., Capodieci, P., Osman, I., Fazzari, M. J., Ferrara, J., Scher, H. I., & Cordon‐Cardo, C. (1999) · PubMed · Cited by 111
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue.
Wang, Y. Z., Hayward, S. W., Donjacour, A. A., Young, P., Jacks, T., Sage, J., Dahiya, R., Cardiff, R. D., Day, M. L., & Cunha, G. R. (2000) · PubMed · Cited by 106
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao, X., Chen, Y. Q., Wu, N., Grignon, D. J., Sakr, W., Porter, A. T., & Honn, K. V. (1995) · PubMed · Cited by 106
Barkley, M. S. (1977) · Hormones and Behavior · doi:10.1016/0018-506x(77)90038-1 · Cited by 105
Allelic loss on chromosome 10 in prostate adenocarcinoma.
Ittmann, M. (1996) · PubMed · Cited by 105
Identification of two distinct deleted regions on chromosome 13 in prostate cancer
Li, C., Larsson, C., Futreal, P. A., Lancaster, J., Phelan, C., Aspenblad, U., Sundelin, B., Liu, Y., Ekman, P., Auer, G., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201554 · Cited by 104
Berg, C. V. D., Guan, X., Hoff, D. V., et al. (1995) · PubMed · Cited by 103
Stackhouse, G. B., Sesterhenn, I. A., Bauer, J. J., Mostofi, F. K., Connelly, R. R., Srivastava, S. K., & Moul, J. W. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(05)68095-0 · Cited by 101
P53 Gene Alterations in Human Prostate Carcinoma
Effert, P. J., McCoy, R. H., Walther, P. J., & Liu, E. T. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35458-7 · Cited by 101
PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate
Dong, J., Sipe, T. W., Hyytinen, E., Li, C., Heise, C. E., McClintock, D. E., Grant, C. D., Chung, L. W. K., & Frierson, H. F. (1998) · Oncogene · doi:10.1038/sj.onc.1202119 · Cited by 100
Dong, Y., Walsh, M. D., McGuckin, M. A., Gabrielli, B. G., Cummings, M. C., Wright, R. G., Hurst, T., Khoo, S. K., & Parsons, P. G. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970220)74:1<57::aid-ijc10>3.0.co;2-f · Cited by 99
Bauer, J. J., Sesterhenn, I. A., Mostofi, K., McLeod, D. G. R., Srivastava, S. K., & Moul, J. W. (1995) · PubMed · Cited by 99
Johnson, M. I., Robinson, M., Marsh, C., Robson, C. N., Neal, D. E., & Hamdy, F. C. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19981201)37:4<223::aid-pros3>3.0.co;2-o · Cited by 96
Androgen receptors in prostate cancer
Bentel, J. M., & Tilley, W. D. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.1510001 · Cited by 95
Concerning a familial association between breast cancer and both prostatic and uterine malignancies
Thiessen, E. U. (1974) · Cancer · Cited by 95
Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer
Dinjens, W. N. M., van der Weiden, M. M., Schroeder, F. H., Bosman, F. T., & Trapman, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560504 · Cited by 94
Elo, J. P., Härkönen, P. K., Kyllönen, A. P., Lukkarinen, O. A., POUTANEN, M. H., Vihko, R., & Vihko, P. (1997) · PubMed · Cited by 92
Lakshmanan, G., Lieuw, K. H., Lim, K.-C., Gu, Y., Grosveld, F. G., Engel, J. D., & Karis, A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1558 · Cited by 91
Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer
Shurbaji, M. S., Kalbfleisch, J. H., & Thurmond, T. S. (1995) · Human Pathology · doi:10.1016/0046-8177(95)90122-1 · Cited by 87
Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.
Rinker-Schaeffer, C. W., Hawkins, A. L., Ru, N., Dong, J., Stoica, G., Griffin, C. A., Ichikawa, T., Barrett, J. C., & Isaacs, J. T. (1994) · PubMed · Cited by 86
Role of p27 in Prostate Carcinogenesis
Macrì, E., & Loda, M. F. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006133620914 · Cited by 86
Commonly occurring loss and mutation of the MXI1 gene in prostate cancer
Prochownik, E. V., Grove, L. E., Deubler, D. A., Zhu, X. L., Stephenson, R. A., Rohr, L. R., Yin, X., & Brothman, A. R. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199808)22:4<295::aid-gcc5>3.3.co;2-r · Cited by 84
Latil, A., Jc, B., Cussenot, O., et al. (1994) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870110208 · Cited by 83
Hormone Resistance in Prostate Cancer
Pilat, M. J., Kamradt, J. M., & Pienta, K. J. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006166511344 · Cited by 78
Prostate cancer progression, metastasis, and gene expression in transgenic mice.
Perez‐Stable, C., Altman, N. H., Mehta, P. P., Deftos, L. J., & Roos, B. A. (1997) · PubMed · Cited by 78
Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis
Macoska, J. A., Micale, M. A., Sakr, W., Benson, P. D., & Wolman, S. R. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870080205 · Cited by 78
Radiation-induced apoptosis mediated by retinoblastoma protein.
Bowen, C., Spiegel, S., & Gelmann, E. P. (1998) · PubMed · Cited by 74
Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.
Matsuyama, H., Pan, Y., Skoog, L. K., et al. (1994) · PubMed · Cited by 72
Growth factors as mediators of androgen action during male urogenital development
Cunha, G. R. (1996) · The Prostate · Cited by 71
Cited by
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00243-0 · Cited by 1,090
Metadata
- Authors
- Abate-Shen, C., & Shen, M. M.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-10-01
- Volume
- 14
- Issue
- 19
- Pages
- 2410-2434
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2064117760
- Cited by
- 735
- References
- 227
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.